Author
Listed:
- Burhan Uyanik
(University of Burgundy Franche-Comté)
- Anastasia R. Goloudina
(University of Burgundy Franche-Comté
Institute of Cytology, RAS)
- Aamir Akbarali
(Center for Center Research, National Cancer Institute)
- Bogdan B. Grigorash
(Institute of Cytology, RAS
NTU Sirius)
- Alexey V. Petukhov
(NTU Sirius
Almazov National Medical Research Centre)
- Sunil Singhal
(University of Pennsylvania)
- Evgeniy Eruslanov
(University of Pennsylvania)
- Jeanne Chaloyard
(University of Burgundy Franche-Comté)
- Lisa Lagorgette
(University of Burgundy Franche-Comté)
- Tarik Hadi
(University of Burgundy Franche-Comté)
- Ekaterina V. Baidyuk
(Institute of Cytology, RAS)
- Hiroyasu Sakai
(Center for Center Research, National Cancer Institute)
- Lino Tessarollo
(Center for Cancer Research, National Cancer Institute)
- Bernhard Ryffel
(University of Orléans, CNRS, UMRP735)
- Sharlyn J. Mazur
(Center for Center Research, National Cancer Institute)
- Frederic Lirussi
(University of Burgundy Franche-Comté
University hospital of Besançon (CHU), 2 Boulevard Fleming)
- Carmen Garrido
(University of Burgundy Franche-Comté
Georges François Leclerc Center)
- Ettore Appella
(Center for Center Research, National Cancer Institute)
- Oleg N. Demidov
(University of Burgundy Franche-Comté
Institute of Cytology, RAS
NTU Sirius)
Abstract
PPM1D/Wip1 is a negative regulator of the tumor suppressor p53 and is overexpressed in several human solid tumors. Recent reports associate gain-of-function mutations of PPM1D in immune cells with worse outcomes for several human cancers. Here we show that mice with genetic knockout of Ppm1d or with conditional knockout of Ppm1d in the hematopoietic system, in myeloid cells, or in neutrophils all display significantly reduced growth of syngeneic melanoma or lung carcinoma tumors. Ppm1d knockout neutrophils infiltrate tumors extensively. Chemical inhibition of Wip1 in human or mouse neutrophils increases anti-tumor phenotypes, p53-dependent expression of co-stimulatory ligands, and proliferation of co-cultured cytotoxic T cells. These results suggest that inhibition of Wip1 in neutrophils enhances immune anti-tumor responses.
Suggested Citation
Burhan Uyanik & Anastasia R. Goloudina & Aamir Akbarali & Bogdan B. Grigorash & Alexey V. Petukhov & Sunil Singhal & Evgeniy Eruslanov & Jeanne Chaloyard & Lisa Lagorgette & Tarik Hadi & Ekaterina V. , 2021.
"Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses,"
Nature Communications, Nature, vol. 12(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23330-6
DOI: 10.1038/s41467-021-23330-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23330-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.